Loading…
Clover Health Investments, Corp. is projected to rise to $5.23 by 2027, a +20% move from its current price of $4.34. CLOV is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $4.20 | $4.34 | $4.49 | +0.04% |
| Aug 2 | $4.15 | $4.34 | $4.55 | +0.09% |
| Aug 3 | $4.11 | $4.35 | $4.60 | +0.13% |
| Aug 4 | $4.07 | $4.35 | $4.64 | +0.17% |
| Aug 5 | $4.04 | $4.35 | $4.68 | +0.21% |
| Aug 6 | $4.02 | $4.35 | $4.72 | +0.26% |
| Aug 7 | $3.99 | $4.35 | $4.75 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.99 | $4.35 | $4.75 | +0.30% |
| Week 2 | $3.86 | $4.37 | $4.94 | +0.60% |
| Week 3 | $3.77 | $4.38 | $5.09 | +0.90% |
| Week 4 | $3.69 | $4.39 | $5.22 | +1.20% |
| Week 5 | $3.63 | $4.41 | $5.35 | +1.50% |
| Week 6 | $3.57 | $4.42 | $5.46 | +1.80% |
| Week 7 | $3.52 | $4.43 | $5.58 | +2.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals.
It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Clover Health Investments, Corp. (CLOV) trades in the Healthcare sector. The current price is $4.32 per share and the market capitalization is $2.28B, with a market ranking of 1816.
The price outlook shows a forecast path with a 2026 average of $4.32 and a range from $1.70 to $5.95, reflecting neutral near-term momentum. The current price aligns with the 2026 average, suggesting limited near-term upside beyond the forecast range.
The longer-term outlook turns bullish in the years that follow, with steadily higher average prices and positive return expectations reflected in the yearly forecasts through 2050.
A major floor 60.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.5% away) — a key level to hold.
The nearest ceiling, 24.7% above — a clean break opens room to run.
A major ceiling 34.6% above — clearing it would confirm fresh momentum.
Key CLOV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLOV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.30 | Buy | $4.34 | Sell |
| MA 10 | $4.46 | Sell | $4.43 | Sell |
| MA 20 | $4.61 | Sell | $4.54 | Sell |
| MA 50 | $4.50 | Sell | $4.32 | Buy |
| MA 100 | $3.40 | Buy | $3.78 | Buy |
| MA 200 | $2.97 | Buy | $3.33 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.82 | Neutral |
| Stoch RSI (14) | 26.13 | Neutral |
| CCI (20) | -83.94 | Neutral |
| Williams %R (14) | -81.36 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -9.96 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 18.64 | Buy |
| TRIX (15) | -0.05 | Sell |
| Awesome (5,34) | -0.51 | Sell |
| Ultimate (7,14,28) | 32.14 | Neutral |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 4.20 | Buy |
| ADX (14) | 17.78 | Neutral |
| ATR (14) | 0.15 | Info |
The 30-day technical picture is bullish overall, with RSI14 at 50. The stock trades near the 50-day simple moving average at $4.42, above the 200-day average of $2.93, suggesting a constructive setup.
Support sits at $4.40 and resistance at $5.41, outlining a defined near-term trading band. Over the past 30 days, the price range has been $3.42 to $5.46, and annualized volatility is 70%, indicating meaningful, but not extreme, price movement.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.70 | $4.34 | $5.94 | 0% | Neutral | |
| $4.09 | $5.23 | $7.11 | +20% | Bullish | |
| $4.74 | $6.27 | $8.90 | +44% | Bullish | |
| $5.90 | $8.03 | $11.80 | +85% | Bullish | |
| $7.53 | $10.52 | $15.90 | +142% | Bullish | |
| $9.03 | $12.91 | $20.00 | +197% | Bullish | |
| $9.49 | $13.86 | $21.96 | +219% | Bullish | |
| $10.35 | $15.43 | $24.92 | +255% | Bullish | |
| $11.42 | $17.36 | $28.56 | +300% | Bullish | |
| $11.68 | $18.09 | $30.26 | +317% | Bullish | |
| $19.57 | $33.05 | $59.31 | +661% | Bullish | |
| $44.05 | $86.59 | $171.97 | +19.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.70 | $4.34 | $5.07 | +0.00% |
| August 2026 | $3.70 | $4.36 | $5.28 | +0.52% |
| September 2026 | $3.79 | $4.51 | $5.54 | +3.42% |
| October 2026 | $3.97 | $4.76 | $5.93 | +5.58% |
| November 2026 | $3.95 | $4.78 | $6.00 | +0.25% |
| December 2026 | $3.85 | $4.68 | $5.94 | -1.99% |
Click any year to see its month-by-month CLOV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CLOV could reach as high as $5.94, with a base case around $4.34 and support toward $1.70 — roughly 0% from $4.34. A consolidation phase looks the most probable path here.
Expect CLOV to range from $4.09 to $7.11 through 2027. The $5.23 average target implies a +20% move from current prices. That is up +20% on the projected 2026 average. Momentum favours further upside here.
The CLOV price prediction for 2028 points to an average of $6.27 (low $4.74, high $8.90) — a potential gain of +44% on today's $4.34. Buyers look set to stay in control over this stretch.
In 2029, CLOV is projected to trade between $5.90 and $11.80, averaging $8.03 — a potential gain of +85% from today's $4.34. That is up +28% on the projected 2028 average. Momentum favours further upside here.
Clover Health Investments, Corp.'s 2030 outlook centres on $10.52, within a $7.53 to $15.90 range. That is up +31% on the projected 2029 average. That marks a +142% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, CLOV could reach as high as $20.00, with a base case around $12.91 and support toward $9.03 — roughly +197% from $4.34. Momentum favours further upside here.
Expect CLOV to range from $9.49 to $21.96 through 2032. The $13.86 average target implies a +219% move from current prices. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The CLOV price prediction for 2033 points to an average of $15.43 (low $10.35, high $24.92) — a potential gain of +255% on today's $4.34. Momentum favours further upside here.
In 2034, CLOV is projected to trade between $11.42 and $28.56, averaging $17.36 — a potential gain of +300% from today's $4.34. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Clover Health Investments, Corp.'s 2035 outlook centres on $18.09, within a $11.68 to $30.26 range. That is up +4% on the projected 2034 average. That marks a +317% change versus current levels. Momentum favours further upside here.
By 2040, CLOV could reach as high as $59.31, with a base case around $33.05 and support toward $19.57 — roughly +661% from $4.34. Buyers look set to stay in control over this stretch.
Expect CLOV to range from $44.05 to $171.97 through 2050. The $86.59 average target implies a +19.0x move from current prices. That is up +162% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CLOV today (≈ 230.414747 CLOV) could be worth
$19,952.55
+$18,952.55 (+1895%) by 2050 · US Dollar
Based on the average projected CLOV price of $86.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLOVwould be worth at today's price.
$1,000 invested in CLOV on Jul 30, 2025 (≈ 344.827575 CLOV) would be worth
$1,496.55
+$496.55 (+49.7%) today · 1.50× · US Dollar
Based on a CLOV entry price of $2.9 vs. today's $4.34.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.55 | $953.85 | -4.6% |
| 1 month ago | $5.24 | $828.24 | -17.2% |
| 3 months ago | $2.71 | $1,601.48 | +60.1% |
| 6 months ago | $2.24 | $1,937.5 | +93.7% |
| 1 year ago | $2.9 | $1,496.55 | +49.7% |
| All time (5.0y) ago | $8.15 | $532.52 | -46.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLOV forecast.
Our base-case forecast reaches $8.70 around 2030.
Implied market cap at $8.70: $3.75B
The multi-year forecast shows sustained upside, with 2026 at an average of $4.32 and 2027 at $5.19, then continuing higher to 2028 at $6.13 and 2029 at $8.01. By 2030, the average target reaches $10.55 with a 144.3% ROI and bullish sentiment.
Looking further out, 2031–2035 push averages toward the mid-teens, with 2035 averaging $17.82 and a 312.6% ROI, continuing the bullish trend. In 2040 the forecast average jumps to $32.27 (ROI 647%) and in 2050 to $85.68 (ROI 1883.3%), both with bullish sentiment.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $10.55, with a min of $7.43, a max of $16.25, and a projected ROI of 144.3% with bullish sentiment.
Forecasts show bullish sentiment from 2027 onward with rising averages and ROIs (e.g., 2027 avg $5.19, 2028 avg $6.13, 2029 avg $8.01, and 2030 avg $10.55), though 2026 is neutral and outcomes are not guaranteed.
Yes, the long-range forecast includes a 2050 max of $175.81, with a 2050 average of $85.68, indicating that reaching $100 is within the forecasted range though not guaranteed.
The 2026 forecast lists an average of $4.32, a minimum of $1.70, a maximum of $5.95, and a 0% ROI with neutral sentiment.
By 2050 the forecast shows an average of $85.68, a min of $41.10, and a max of $175.81, with a 1883.3% ROI and bullish sentiment.
Clover Health Investments, Corp. Community Discussion
0Share your Clover Health Investments, Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.